Lymph node micrometastasis and prognosis in patients with oesophageal squamous cell carcinoma
Lymph node micrometastasis and prognosis in patients with oesophageal squamous cell carcinoma
复制标题
DOI：
10.1046/j.1365-2168.2001.01687.x
复制
发表时间：
2001-03-01
影响因子：
9.6
通讯作者：
Imamura, M
中科院分区：
文献类型：
--
作者：
Sato, F;Shimada, Y;Imamura, M
背景：本研究旨在探讨病理淋巴结阴性(PN(0))食管鳞癌的淋巴结微转移是否具有预后价值。方法：对50例原发于PN(0)的食管鳞癌患者行系统淋巴清扫，共获得1840个淋巴结。用抗细胞角蛋白抗体(AE1/AE3)进行免疫组织化学检测，将新发现的淋巴结微转移归类为微转移。此外，淋巴结微转移可分为三个阶段：1期，单个AE1/AE3阳性细胞；2期，多个单个阳性细胞；3期，一个或多个阳性簇。微转移分期越高，肿瘤(PT)大小越大(P=0.023)。9名患者出现复发肿瘤。然而，有或无微转移患者的复发频率相似(分别为5/20和4/30，P=0.25)。30例无微转移患者中23例存活，20例微转移患者中15例存活(5年生存率分别为75%和78%，P=0.91)。30例无微转移患者中26例无复发，20例微转移患者中15例无复发(5年无复发生存率分别为86%和73%，P=0.37)。微转移分期与预后无显著差异。多因素分析也显示微转移不是一个独立的预后因素(P=0.73)。结论：免疫组织化学检测淋巴结微转移可能是肿瘤细胞淋巴转移的一个指标。然而，微转移的存在对无淋巴结转移的食管鳞癌患者的预后没有影响。
Background: The purpose of this study was to investigate whether the presence of lymph node micrometastasis in pathological lymph node-negative (pN(0)) oesophageal squamous cell carcinoma had prognostic value.Methods: Some 1840 lymph nodes were obtained from 50 patients with pN(0) oesophageal squamous cell carcinoma who underwent curative resection of the primary tumour with systematic lymphadenectomy. These lymph nodes were examined immunohistochemically with anticytokeratin antibody (AE1/AE3), Lymph node micrometastases newly detected by immunohistochemistry were classified as micrometastasis. Additionally, lymph node micrometastases were classified into three stages: stage 1, one individual AE1/AE3-positive cell; stage 2, multiple individual positive cells; stage 3, one or multiple positive clusters.Results: Micrometastases were detected in 20 patients (40 per cent). A higher stage of micrometastasis was associated with greater pathological tumour (pT) size (P = 0.023). Recurrent tumours developed in nine patients. However, the frequency of recurrence was similar in patients with, or without, micrometastasis (five of 20 and four of 30 patients respectively; P = 0.25). Twenty-three of 30 patients without micrometastasis survived, whereas 15 of 20 patients with micrometastasis were still alive (5-year overall survival 75 and 78 percent respectively, P = 0.91). Twenty-six of 30 patients without micrometastasis had no recurrence, whereas 15 of 20 patients with micrometastasis had no recurrence (5-year relapse-free survival 86 and 73 per cent respectively, P = 0.37). There was no significant difference in prognosis with respect to the stages of micrometastasis. Multivariate analysis also showed that micrometastasis was not an independent prognostic factor (P = 0.73).Conclusion: Immunohistochemical detection of lymph node micrometastasis may be an indicator of lymphatic dissemination of tumour cells. However, the presence of micrometastasis had no impact on the prognosis of node-negative patients with oesophageal squamous cell carcinoma.